Mathematical modelling of radiotherapy strategies for early breast cancer

被引:82
作者
Enderling, Heiko
Anderson, Alexander R. A.
Chaplain, Mark A. J.
Munro, Alastair J.
Vaidya, Jayant S. [1 ]
机构
[1] Univ Dundee, Div Math, Dundee DD1 4HN, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland
关键词
mathematical modelling; tumour invasion; breast cancer; radiotherapy; targit; intraoperative radiotherapy; local recurrence;
D O I
10.1016/j.jtbi.2005.11.015
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Targeted intraolperative radiotherapy (Targit) is a new concept of partial breast irradiation where single fraction radiotherapy is delivered directly to the tumour bed. Apart from logistic advantages, this strategy minimizes the risk of missing the tumour bed and avoids delay between surgery and radiotherapy. It is presently being compared with the standard fractionated external beam radiotherapy (EBRT) in randomized trials. In this paper we present a mathematical model for the growth and invasion of a solid tumour into a domain of tissue (in this case breast tissue), and then a model for surgery and radiation treatment of this tumour. We use the established linear-quadratic (LQ) model to compute the survival probabilities for both tumour cells and irradiated breast tissue and then simulate the effects of conventional EBRT and Targit. True local recurrence of the tumour could arise either from stray tumour cells, or the tumour bed that harbours morphologically normal cells having a predisposition to genetic changes, such as a loss of heterozygosity (LOH) in genes that are crucial for tumourigenesis, e.g. tumour suppressor genes (TSGs). Our mathematical model predicts that the single high dose of radiotherapy delivered by Targit would result in eliminating all these sources of recurrence, whereas the fractionated EBRT would eliminate stray tumour cells, but allow (by virtue of its very schedule) the cells with LOH in TSGs or cell-cycle checkpoint genes to pass on low-dose radiation-induced DNA damage and consequently mutations that may favour the development of a new tumour. The mathematical model presented here is an initial attempt to model a biologically complex phenomenon that has until now received little attention in the literature and provides a 'proof of principle' that it is possible to produce clinically testable hypotheses on the effects of different approaches of radiotherapy for breast cancer. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:158 / 171
页数:14
相关论文
共 63 条
[21]   Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [J].
Fisher, B ;
Anderson, S ;
Bryant, J ;
Margolese, RG ;
Deutsch, M ;
Fisher, ER ;
Jeong, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1233-1241
[22]   Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer [J].
Försti, A ;
Louhelainen, J ;
Söderberg, M ;
Wijkström, H ;
Hemminki, K .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (11) :1372-1380
[23]   c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer:: a retrospective study [J].
Fritz, P ;
Cabrera, CM ;
Dippon, J ;
Gerteis, A ;
Simon, W ;
Aulitzky, WE ;
van der Kuip, H .
BREAST CANCER RESEARCH, 2005, 7 (03) :R374-R384
[24]   Clinical implications of radiation-induced genomic instability [J].
Goldberg, Z .
ONCOGENE, 2003, 22 (45) :7011-7017
[25]   Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning [J].
Guerrero, M ;
Li, XA .
PHYSICS IN MEDICINE AND BIOLOGY, 2003, 48 (20) :3307-3326
[26]   Does tumor growth follow a "universal law"? [J].
Guiot, C ;
Degiorgis, PG ;
Delsanto, PP ;
Gabriele, P ;
Deisboeck, TS .
JOURNAL OF THEORETICAL BIOLOGY, 2003, 225 (02) :147-151
[27]   Radiobiological aspects of intraoperative radiotherapy (IORT) with isotropic low-energy X rays for early-stage breast cancer [J].
Herskind, C ;
Steil, V ;
Kraus-Tiefenbacher, U ;
Wenz, F .
RADIATION RESEARCH, 2005, 163 (02) :208-215
[28]   M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis -: art. no. 4 [J].
Jamieson, TA ;
Brizel, DM ;
Killian, JK ;
Oka, Y ;
Jang, HS ;
Fu, XL ;
Clough, RW ;
Vollmer, RT ;
Anscher, MS ;
Jirtle, RL .
BMC CANCER, 2003, 3 (1)
[29]   A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena [J].
Kopans, DB ;
Rafferty, E ;
Georgian-Smith, D ;
Yeh, E ;
D'Alessandro, H ;
Moore, R ;
Hughes, K ;
Halpern, E .
CANCER, 2003, 97 (12) :2951-2959
[30]   Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics [J].
Lacroix, M ;
Toillon, RA ;
Leclercq, G .
ENDOCRINE-RELATED CANCER, 2004, 11 (03) :497-522